Skip to main content
Clinical Trials/NCT06587646
NCT06587646RecruitingNot Applicable

A Feasibility Study to Assess a "Virtual" (vEUA) Technology to Improve the Management of Perianal Crohn's Disease

Nottingham University Hospitals NHS Trust2 sites in 1 country30 target enrollmentStarted: July 23, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
30
Locations
2
Primary Endpoint
Clinical disease activity assessment

Study Overview

Brief Summary

Crohn's is an inflammatory condition that can affect any part of the gut. Over half a million people in the UK live with Crohn's disease and about a quarter will develop a fistula near their back passage. A fistula is an abnormal connection between two surfaces of the body. These can be hard to treat causing pain and infection. Surgery is required to control infection and in extreme cases this can lead to incontinence or even formation of a stoma, when the bowel is brought to the skin and waste goes into a bag on the tummy wall.

Patients with perianal Crohn's are usually referred to a surgeon by their medical team and subsequently undergo a MRI scan and an examination under anaesthesia (EUA) where abscesses (regions of fluid build-up) will be drained and a seton (plastic sling or suture) inserted through the fistula, or the fistula opened to the skin if this will not affect continence. They are then started on specialist medication by the gastroenterologists (gut doctors).

Abscesses or fistulas can be difficult to identify during EUA, leading to ongoing infection and repeat procedures. This causes additional scarring and delays the medical treatment that can allow fistulas to heal. Multiple or incorrectly performed operations can also damage the muscles that help hold stool in the back passage, leading to incontinence.

We believe that improving how information is communicated between radiology (who report scans) and surgeons will improve their ability to identify and manage all fistulas and collections at operation. Here is a typical MRI report given to the surgeon by the radiologist:

'There is a low intersphincteric fistula with predicted internal opening in the lower half of the anal canal at dentate line level between 5-6 o'clock that passes in the intersphincteric plane to the anal verge between 5-6 o'clock.'

This protocol was developed in an era when written communication was really the only way to convey information between specialists. Jargon aside, surgeons face significant difficulty interpreting such written descriptions of a complex 3D structure and using it as a surgical guide. Indeed, a major complaint from surgeons is how difficult it is to get real value from these preoperative MRIs, which cost time and money.

With advances in digital technology, we believe this system can be vastly improved.

Motilent (a UK SME specialising in technology to improve the management of Crohn's Disease) has developed a sophisticated visualisation tool to provide a 3D model of the fistula and surrounding structures, we call this tool Virtual EUA (vEUA), allowing the surgeon to better understand the anatomy of the problem in conjunction with radiology.

We are aiming to establish whether vEUA changes the behaviour of colorectal surgeons, increasing confidence in identifying and dealing with fistulas, which will reduce the number of surgical procedures required and improve the quality of care, resulting in a cost saving for the hospital and a much-needed step towards more effective management of perianal Crohn's.

Any patient taking part in the trial will be randomly allocated to have the 3D model utilised in their care or standard care. We will use pre- and post-surgical patient questionnaires, surgical questionnaires and MRI imaging to establish if vEUA is safe and effective in improving the care of patients with perianal Crohn's.

Detailed Description

The development of the vEUA tool is a significant advancement in the management of perianal Crohn's disease fistulas. Mismanagement of fistulas can lead to significant complications, such as abscesses, scarring, and delayed healing. Additionally, multiple surgeries can cause damage to the anal sphincter muscles, leading to incontinence and other issues.

With the vEUA tool, surgeons can now have a more precise and accurate understanding of the fistula anatomy before conducting the examination under anaesthesia. This approach can significantly reduce the risk of misdiagnosis and subsequent complications. The tools 3D visualization capability allows surgeons to assess the extent of the fistula, its location, and any associated abscesses or inflammation. This information is essential for planning the surgery and ensuring that the procedure is as minimally invasive as possible.

In addition to improving surgical planning, the vEUA tool can also enhance post-operative care. The 3D model generated by the tool can be used to monitor the healing process and ensure that the fistula has healed correctly. This approach reduces the need for multiple follow-up surgeries and promotes faster healing. With the vEUA tool, surgeons can better plan the surgery to avoid damaging the muscles, promoting faster healing and reducing the risk of long-term complications.

Overall, the development of the vEUA tool represents a significant breakthrough in the management of Crohn's disease and perianal fistulas. The tool's ability to provide a more precise and accurate understanding of the fistula's anatomy will reduce the risk of misdiagnosis, promote faster healing, and improve patient outcomes.

vEUA generates a disease activity score based on T2 enhancement and a volumetric measurement of the fistula tract, providing a more detailed analysis of the fistula and surrounding structures.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Ability to give informed consent
  • Active perianal Crohn's disease as defined by clinical assessment with fistula or abscess formation
  • A clinical decision has been taken that surgery is required for perianal disease
  • Ages of 18-75

Exclusion Criteria

  • Inability to consent
  • history of Proctectomy,
  • absence of a diagnosis of Crohn's disease,
  • perianal fistulising disease not secondary to Crohn's disease,
  • Rectovaginal fistulas
  • Malignant disease
  • Significant cardiovascular or respiratory disease
  • Neurological or cognitive impairment
  • Significant physical disability
  • Significant hepatic disease or renal failure
  • Subjects currently (or in the last three months) participating in another research project
  • Pregnancy or breastfeeding
  • If MRI is contraindicated (e.g. pacemaker).
  • under 18 years old or over 75 years old

Outcomes

Primary Outcomes

Clinical disease activity assessment

Time Frame: Enrollment to 3 months post-intervention

Clinical outcome measures will be assessed by Perianal Disease Activity Score (PDAI)

Patient reported outcomes

Time Frame: Enrollment to 3 months post-intervention

Inflammatory bowel disease (IBD) specific patient outcome measures will be collected on recruitment and after intervention using The Crohn's Anal Fistula Quality of Life (CAF-QoL) scale

Biochemical disease activity monitoring

Time Frame: Enrollment to 3 months post-intervention

Biochemical disease activity will be measured byC-reactive protein (CRP)

Disease control at surgery / surgical success

Time Frame: 4-8 weeks post-surgery

To assess disease control at surgery patients will undergo a repeat MRI scan of the pelvis at 4-8 weeks post-procedure to look for undrained collections

Secondary Outcomes

  • Evaluation of surgical confidence and opinion data(up to 4 weeks pre and up to 4 weeks post-surgical intervention)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials